RB

Rekha Bhausaheb Karande

Active Director Director DIN 09665597
DIN 09665597 First appointment Jul 2022 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2022
Shareholding value •••• Premium profile

About Rekha Bhausaheb Karande

Data last updated:

Rekha Bhausaheb Karande is a Director at Aurixa Pharmaceuticals Private Limited (since 2022). The company operates in Trading. Aurixa Pharmaceuticals Private Limited reported revenue of ₹32.7 Lakh (FY 2025).

DIN 09665597
Primary Designation Director
Industry Trading
First Appointment 07 Jul 2022
Oldest Company Age 4 yrs
Largest company Aurixa Pharmaceuticals Private Limited · ₹32.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Jul 20222022₹32.7 Lakh (FY 2025)Active

Board colleagues of Rekha Bhausaheb Karande

NameDINCompanyDesignation
Dnyaneshwar Ankush Sul09665596Aurixa Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Aurixa Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rekha Bhausaheb Karande

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rekha Bhausaheb Karande

Rekha Bhausaheb Karande currently holds 1 directorship: Aurixa Pharmaceuticals Private Limited (Director, since 07 Jul 2022, revenue ₹32.7 Lakh (FY 2025)).

Rekha Bhausaheb Karande was first appointed on 07 Jul 2022 as Director at Aurixa Pharmaceuticals Private Limited.

The current boards of Rekha Bhausaheb Karande's companies include Dnyaneshwar Ankush Sul (Aurixa Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available